Leaders across the Center for Drug Evaluation and Research are applying lessons learned from the pandemic on its response to therapies for emerging variants.
Hiring for a variety of skills and backgrounds will ensure the defense community has the scope of talent necessary to fully modernize and maintain its strategic edge.
The agency is integrating new technologies and policies to connect veterans with health experts and innovative care solutions throughout and beyond COVID-19.
How the department responded to COVID-19 and collaborated with agencies will inform future strategies for working more efficiently.
The agency outlines exemptions and waivers that maintain strengthened supply chain efforts while also enabling a strong pandemic response.
With surges in cyber crime, leaders from across government came together to help both public and private organizations develop cyber strategies.
As the amount of digital data continues to grow, e-discovery is reshaping how organizations manage information for legal requirements and compliance.
The Rapid Acceleration of Diagnostics program, or RADx, brought scalability and advancements to COVID-19 testing.
VA’s acting deputy secretary discusses new innovations to support veterans and how VA will prepare for a post-COVID world.
FDA’s acting commissioner emphasizes the importance of IT infrastructure modernization to improve speed and quality of operations.
Cloud, AI, machine learning and wearables are helping drive agencies' mission and data-driven decision-making.
SAMHSA is providing communities with mental health resources.
Cybersecurity leaders discuss how the agency is implementing new cyber controls to protect medical device integrity.
HHS’ at-home and self-testing services could help the public maintain health safety amid reopening plans.
VA's benefits chief sees promise in emerging technology to delivering benefits faster.
Data sharing and interoperability are key for data quality and governance.
A new tool shows promise in increasing success rates of detecting cancer, and a new data strategy shows promise for future medical devices.
The office’s director explains how it has leveraged new practices to quickly review and approve treatments amid the COVID-19 pandemic.
Chief data officers across HHS are strengthening platforms that speed up data collection and management.